INzululwazi eyiNtloko
Wenqiang Yu, Ph.D.
●INzululwazi eyiNtloko yeNkqubo yeSizwe "973";
●Unjingalwazi oqeshwe ngokuKhethekileyo weNkqubo yeZifundo zeChang Jiang;
●I-PI, iZiko le-Epigenetics, i-Institute of Biomedical Sciences Fudan University;
●Umphandi oqeshwe ngokuKhethekileyo kunye noMlawuli onguGqirha weYunivesithi yaseFudan;
●Inkokeli yeKomiti yeNgcali ye-Methylation Marker yeKomiti ye-Tumor Marker ye-Anti-Cancer Association yaseTshayina.
Ngo-1989, wathweswa isidanga kwiYunivesithi yezoNyango yesiFne waze wafumana isidanga sobuGqirha;
Ngo-2001, wafumana isiDanga sakhe sobuGqirha kwiYunivesithi yezoNyango yesine;
Ukususela kwi-2001-2004, ifumene i-Postdoctoral kwiSebe loPhuhliso kunye neGenetics, iYunivesithi yaseUppsala, eSweden;
Ukususela ngo-2004-2007, wafumana i-Postdoctoral kwi-Hopkins University School of Medicine, e-United States;
Okwangoku, uNjingalwazi u-Yu yi-PI kunye nophando lwe-Institutes of Biomedical Sciences yeYunivesithi yaseFudan, kunye noSekela Mlawuli oyiNtloko weZiko leGenomics kunye ne-Epigenomics yeYunivesithi yaseFudan.Ukuphumelela kwakhe kuphando kuye kwapapashwa kwiijenali zezemfundo eziphezulu zamazwe ngamazwe ezifana,Indalo, Imfuzo yendalokwayeJAMA.
zibhalwe kwiijenali zezemfundo eziphezulu zamazwe ngamazwe ezifana neNdalo, i-Nature Genetics kunye ne-JAMA, enempembelelo ephezulu yamanqaku angama-38.1.
CEO
Lin Hua
Isidanga soQoqosho saseShanghai JiaoIYunivesithi yaseTong.Wenza njengoMphathi oLawulayo weSebe leNkampani eLuluhlu lweGuosen Securities, iqabane le-XIANGDU CAPITAL, iqabane elisungula i-CHOBE CAPITAL.Njengenkokeli yeqela, ukhuthaze ukutyala iinkampani ezininzi eziphumeleleyo.
ObiO(688238): CGT CDMO umenzi kunye nomthamo omkhulu;
I-Novoprotein (688137): umthengisi wezinto eziluhlaza ojolise kwiprotheni ephinda iphinde iphinde iphinde iphinde iphinde iphinde iphinde iphinde iphinde iphinde iphinde iphinde iphinde ibuyele kwiprotheni.
I-Leadsynbio: inkampani ehamba phambili kwibhayoloji yokwenziwa;
I-SinoBay: amashishini onyango lwethumba ekujoliswe kulo
I-Quectel(603236): elona shishini likhulu lemodyuli yonxibelelwano engenazingcingo
XinpelTek: ingqwalasela kwi-wireless PA RF chip ishishini;
I-DGene: gxila kwishishini ledijithali le-3D
Ividiyo ++: ishishini le-unicorn kwindawo ye-AI
Ngaphezulu kweshumi leminyaka kwimarike eyinkunzi, uNksz Hua uqokelele amava amakhulu kulawulo lweshishini notyalo-mali.
R&D uMlawuli
U-Wei Li, Ph.D.
UGqirha uLi usebenze njengoPhando oDityaniswayo kwiZiko leSayensi yezeNzululwazi yeFudan iminyaka elishumi.Uchophele iiprojekthi zophando ezi-3 eziquka iNational Natural Science Foundation yaseTshayina,iProjekthi yophando oluzimeleyo yokwazisa iitalentekwaye njl.Ukwathathe inxaxheba kwiiprojekthi ezininzi zesizwe, kuquka iProjekthi yeSizwe ye-973, iProjekthi ePhambili yeSizwe seSayensi yeNdalo kunye nokunye.Upapashe amaphepha e-16 eSCI njengombhali wokuqala okanye umbhali ohambelana nawoUphando lweGenome, i-eBiomedicine, I-Acid yeNyukliya Uphando kunye njl.(I-Aggregate Impact Factor 158.97).
Owona mdla wophando:
1. Ukuphuhliswa kwe-epigenetic algorithms kunye nezifundo ezininzi ze-omics ze-tumor pathogenesis.Isisombululo esisodwa sesiseko se-genome-wide DNA methylation sequencing platform analysis (WGPS algorithm) yasekwa kwinqanaba lokuqala.Emva koko imephu yokuqala ye-genome-wide ye-DNA methylation yeeseli zesibindi somntu sele ifunyenwe.Ngeli xesha, wanika indlela entsha yokuthulisa i-tumor suppressor gene kumbono we-epigenetics.
2. Isikrini se-biomarkers eziqhelekileyo zokuziphatha okubi kwiintlobo ezininzi zomhlaza ngedatha ye-multi-omics.Ngokusekelwe kwiindlela ze-WGPS, siye sahlola iimpawu ezikhethekileyo ze-hypermethylation phakathi kwamathumba kunye nesiqhelo.
3. Uphando malunga ne-pathogenesis ye-gene transcriptal activation yi-NamiRNA: Iklasi ye-nuclear miRNA, esayithiye ngokuba yi-NamiRNA (i-Nuclear Activate miRNA).
INjineli yeR&D yoNyango
Meigui Wang, Ph.D.
UGqirha Wang wamfumana iPh.D.isidanga kwiYunivesithi yezoNyango yaseMazantsi ngo-2019. Uye waqhubela phambili noqeqesho olusemgangathweni lwabahlali kwiSibhedlele esiNxulumene neSithathu seYunivesithi yaseSun Yat-sen(2019-2021).Umdla wakhe weklinikhi kukuxilongwa kunye nokunyangwa komhlaza wentloko kunye nentamo njengomhlaza we-laryngeal kunye ne-nasopharyngeal carcinoma.Umdla wakhe wophando ugxile ekuxilongeni kwangoko kwe-nasopharyngeal carcinoma.
INjineli yeR&D yoNyango
Yaping Dong, Ph.D.
UGqirha Dong wafumana iPh.D.isidanga kumayeza eklinikhi kwiYunivesithi yezoNyango yaseFujian ngo-2020, kwaye yenza uphando lwasemva kobugqirha kwiYunivesithi yaseFudan kwiziko lomhlaza laseShanghai ukusuka ngo-2020 ukuya kowama-2022. Njengoyena mthathi-nxaxheba ophambili, wathatha inxaxheba kwiiProjekthi ezininzi zeSizwe, kubandakanywa iSebe lezeNzululwazi kunye neTekhnoloji yeNkqubo ePhambili “ Uphuhliso oluNtsha olubalulekileyo lweziyobisi”, iSiseko seSizwe seSayensi yeNdalo yaseTshayina njalo njalo.Upapashe amaphepha amaninzi akumgangatho ophezulu kwiActa Pharmaceutica Sinica B, Acta Pharmacologica Sinica kunye neRadiation Oncology.